Materials and methods

QUALITY CONTROL EXCHANGE
The 29 laboratories who took part in the exchange were requested to supply details of their methods and to designate the cut off value which they considered differentiated normal from abnormally raised values (i.e., upper normal limit). Test serum samples were distributed to the laboratories on two occasions approximately three months apart. There were four test samples on the first occasion, A to D. A, B, and C consisted of standards containing RF in increasing quantities (vide infra) for use in assessing the validity of the method and to allow the construction of a standard curve, and sample D was an 'unknown' seropositive specimen. On the second occasion a further four samples E, F, G, and H were circulated. Samples E and H were duplicates of A to determine within assay and between assay reproducibility; sample G was a duplicate of D to compare values between laboratories and to determine between assay reproducibility; and sample F was without detectable RF to detect false positives. (Table 1) . A number of laboratories used more than one method to measure RF, the most popular being a commercially derived latex agglutination technique (Table 2 ). In addition, a wide variety of other methods were noted, and only one laboratory was using a locally developed assay (ELISA).
Most laboratories were able to demonstrate the validity of their method as reflected by increasing levels of RF when measuring samples A to C, but there were two notable exceptions-laboratories Nos 17 and 18 (Fig. 1) . It is also apparent from this figure that the quoted upper normal limit of RF varied considerably between laboratories, and a wide variation was observed between laboratories when this value was compared with sample A which was designed to contain low but discriminating levels of RF. In some laboratories (e.g., Nos 26 and 30) the quoted upper normal limit was well below that obtained for this sample, while in others (e.g., 9 and 28) it was well above this level. Furthermore, three laboratories (Nos 17, 20, and 40) detected RF in the seronegative sample F (i.e., false positive). Using samples A, B, and C as internal standards to construct a standard curve, most laboratories (21/29) correctly identified specimen D as falling at or between standards B and C (Fig. 1) . The mean difference in titre (log2) (SD) for within assay duplicates (samples E and H) was 0-29 (0-83), whereas for between assay duplicates (samples D and G) it was 0-77 (0-66).
Discussion
This SEAPAL quality control analysis of RF measurement in 29 diagnostic laboratories in 12 countries has confirmed the results of previous similar studies showing wide variation in RF levels between laboratories even when similar methods are compared.3 For example, in the present study a 30-fold difference (from 1/40 to 1/1280) was found on the same seropositive serum (sample D) using the latex agglutination technique. This gross discordance was greatly improved, however, by the inclusion of the local reference standard A, B, and C, suggesting that interlaboratory variation could be markedly diminished by this approach, and this finding is in accord with other studies. 6 It was disappointing to note that even though an international reference preparation of RF has been available for 15 years7 and has been strongly recommended as improving concordance between laboratories, only eight laboratories were expressing their results in international units.
Most laboratories were able to demonstrate the validity of their methods as reflected by linearity with increasing quantities of RF (standard A to C) and had acceptable within assay and between assay precision. There were some notable exceptions, however, and it is hoped that one of the benefits of this study will be to alert such laboratories. 
